Advanced Biomed Inc.
ADVB
$0.71
$0.074211.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 03/31/2024 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | -- | -- | |
| Cost of Revenue | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | |
| SG&A Expenses | 512.30K | 282.30K | 338.30K | 431.90K | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 762.70K | 525.70K | 520.00K | 745.40K | |
| Operating Income | -762.70K | -525.70K | -520.00K | -745.40K | |
| Income Before Tax | -1.38M | -907.90K | -265.60K | -1.06M | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -1.38M | -907.90K | -265.60K | -1.06M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -1.38M | -907.90K | -265.60K | -1.06M | |
| EBIT | -762.70K | -525.70K | -520.00K | -745.40K | |
| EBITDA | -684.60K | -426.70K | -417.80K | -662.40K | |
| EPS Basic | -0.07 | -0.05 | -0.01 | -0.05 | |
| Normalized Basic EPS | -0.04 | -0.03 | -0.01 | -0.03 | |
| EPS Diluted | -0.07 | -0.05 | -0.01 | -0.05 | |
| Normalized Diluted EPS | -0.04 | -0.03 | -0.01 | -0.03 | |
| Average Basic Shares Outstanding | 20.48M | 20.00M | 20.00M | 20.00M | |
| Average Diluted Shares Outstanding | 20.48M | 20.00M | 20.00M | 20.00M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |